Evotec SE (EVO) Return on Sales (2009 - 2025)
Evotec SE (EVO) posted Return on Sales of 4.08% for Q4 2025, down 156093.38% sequentially from 0.0% in Q3 2025, and up 477.0% YoY from 0.71% in Q4 2024.
Evotec SE (EVO) Return on Sales (2009 - 2025) Analysis & Trends
Evotec SE has reported Return on Sales for 9 years, with the latest figure at 4.08% in Q4 2025.
- Quarterly Return on Sales rose 477.0% year-over-year to 4.08% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.3% (up 34.0% YoY) and the FY2025 annual result came in at 1313.0%, up 114721.0% from the prior year.
- Return on Sales slipped to 4.08% in Q4 2025 per EVO's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 4.99% in Q4 2021 and troughed at 8.86% in Q4 2024.
- A 5-year average of 0.85% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2021 and 2022: Return on Sales soared 482 bps in 2021, then tumbled 844 bps in 2022.
- Over 5 years, Return on Sales stood at 4.99% in 2021, then tumbled by 169 bps to 3.44% in 2022, then soared by 58 bps to 1.45% in 2023, then plunged by 513 bps to 8.86% in 2024, then jumped by 54 bps to 4.08% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 4.08%, 0.0%, and 8.86% for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.08% |
| Sep 30, 2025 | 0.00% |
| Dec 31, 2024 | -8.86% |
| Sep 30, 2024 | 0.00% |
| Dec 31, 2023 | -1.45% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | -3.44% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 4.99% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.17% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2010 | 0.00% |
| Jun 30, 2010 | 0.00% |
| Mar 31, 2010 | 0.00% |